Javascript must be enabled to continue!
Targeting Noncanonical TEAD Axis to Overcome DNA Repair-Driven Chemoresistance
View through CrossRef
Summary
How transcription factors contribute to DNA damage repair (DDR) independent of canonical gene regulation remains poorly understood. Here, we show that DNA double-strand break (DSB) triggers a functional state transition in TEAD, disengaging it from YAP-dependent transcription and translocating it to DNA lesions as a chromatin-associated DDR factor. Upon genotoxic stress, TEAD is rapidly recruited to damaged chromatin through a biphasic mechanism involving early poly(ADP-ribose)-dependent recruitment followed by ATM-driven γH2AX-mediated retention. At DNA lesions, TEAD constrains chromatin over-relaxation, suppresses excessive end resection, and promotes non-homologous end joining (NHEJ) independent of its canonical function. Conserved residues within the TEA domain mediate this noncanonical chromatin engagement of TEAD and define a druggable N-terminal interface. Pharmacological targeting of this interface impaired TEAD-dependent DSB repair and sensitized tumors to chemotherapy. Together, these findings establish noncanonical TEAD as a critical DNA repair factor and a clinically actionable driver of chemoresistance, while providing a conceptual framework for understanding how broader families of transcription factors may be repurposed as targetable DNA damage regulators in cancer.
Title: Targeting Noncanonical TEAD Axis to Overcome DNA Repair-Driven Chemoresistance
Description:
Summary
How transcription factors contribute to DNA damage repair (DDR) independent of canonical gene regulation remains poorly understood.
Here, we show that DNA double-strand break (DSB) triggers a functional state transition in TEAD, disengaging it from YAP-dependent transcription and translocating it to DNA lesions as a chromatin-associated DDR factor.
Upon genotoxic stress, TEAD is rapidly recruited to damaged chromatin through a biphasic mechanism involving early poly(ADP-ribose)-dependent recruitment followed by ATM-driven γH2AX-mediated retention.
At DNA lesions, TEAD constrains chromatin over-relaxation, suppresses excessive end resection, and promotes non-homologous end joining (NHEJ) independent of its canonical function.
Conserved residues within the TEA domain mediate this noncanonical chromatin engagement of TEAD and define a druggable N-terminal interface.
Pharmacological targeting of this interface impaired TEAD-dependent DSB repair and sensitized tumors to chemotherapy.
Together, these findings establish noncanonical TEAD as a critical DNA repair factor and a clinically actionable driver of chemoresistance, while providing a conceptual framework for understanding how broader families of transcription factors may be repurposed as targetable DNA damage regulators in cancer.
Related Results
Abstract LB029: Degraders of TEAD transcription factors based on interface 3 binders
Abstract LB029: Degraders of TEAD transcription factors based on interface 3 binders
Abstract
TEAD transcription factors have emerged as clinically validated targets for Hippo-altered cancers, e.g. mesothelioma driven by NF2 inactivation/deficiency. ...
Comparison of YAP/TAZ and TEAD activators on cellular models
Comparison of YAP/TAZ and TEAD activators on cellular models
Comparaison des effets de différents activateurs de YAP/TAZ et TEAD sur plusieurs modèles cellulaires
La voie Hippo (HP) consiste en une cascade de kinases qui cont...
Abstract 3098: Leukemia stem cells demonstrate enhanced DNA damage repair and chemoresistance in AML
Abstract 3098: Leukemia stem cells demonstrate enhanced DNA damage repair and chemoresistance in AML
Abstract
Leukemia stem cells demonstrate enhanced DNA damage repair and chemoresistance in AML
Relapse of acute myeloid leukemia (AML) is common and t...
Abstract A21: Enhancing chemotherapeutic responses in CNS malignancy through suppression of hyperactive DNA damage repair pathways
Abstract A21: Enhancing chemotherapeutic responses in CNS malignancy through suppression of hyperactive DNA damage repair pathways
Abstract
Introduction: We are targeting DNA repair pathways to enhance existing chemoradiotherapeutic strategies against medulloblastoma (MB) and malignant glioma (M...
Abstract 2693: Targeting the Hippo-YAP pathway with novel small-molecule inhibitors of the YAP-TEAD transcription activity
Abstract 2693: Targeting the Hippo-YAP pathway with novel small-molecule inhibitors of the YAP-TEAD transcription activity
Abstract
We have discovered and are developing multiple novel small molecule medicines targeting the Hippo-YAP pathway. Consisting of upstream regulatory components,...
The role of non-coding oligonucleotides in DNA repair regulation
The role of non-coding oligonucleotides in DNA repair regulation
<p dir="ltr">The integrity of DNA is constantly threatened by damaging effects from exoge- nous and endogenous sources. Genetic alterations can cause neurodegenerative disord...
Abstract 2200: A rational approach for discovery of inhibitors of YAP-TEAD interaction
Abstract 2200: A rational approach for discovery of inhibitors of YAP-TEAD interaction
Abstract
The Hippo signalling pathway plays a major role in organ growth regulation and tumorigenesis. By sensing contact inhibition, the central kinase network of t...
Abstract A45: In silico drug discovery targeting Hippo pathway and YAP-TEAD protein-protein interactions for small-molecule anticancer agent
Abstract A45: In silico drug discovery targeting Hippo pathway and YAP-TEAD protein-protein interactions for small-molecule anticancer agent
Abstract
The Hippo pathway is one of the important pathways regulating tissue growth and proliferation. Dysregulation of this pathway can result in overgrowth of phe...

